FDA approves Dompé’s Oxervate for rare eye disease treatment
Dompé farmaceutici, an Italian pharmaceutical company, has achieved a milestone with the U.S. Food and Drug Administration (FDA) approval of Oxervate (cenegermin) eye drops for ... Read More